A Historical Perspective and Update on Robotic Mitral Valve Surgery

<b>Background/Objectives</b>: Minimally invasive techniques for mitral valve repair have evolved over the past thirty years and include mini-thoracotomies and the robotic platform. This study provides a historical perspective on minimally invasive mitral valve approaches and evaluates long-term outcomes of a large series of robotic mitral valve repairs. <b>Methods</b>: A single-institution, prospectively maintained registry was used to evaluate robotic mitral valve repairs performed by four surgeons from 2005 to 2023. There were 1412 robotic mitral valve repairs performed during this time and stratified by the first 120 and subsequent patients. We evaluated operative outcomes and freedom from more than 2+ mitral regurgitation at five years as well as ten-year survival. <b>Results</b>: Of the 1412 robotic mitral valve repairs performed, 93.6% (<i>n</i> = 1322) were for degenerative disease. Compared to the first 120 patients, the subsequent patients had a significant reduction in cross-clamp time (112 (IQR = 103-130) versus 75 (IQR = 65-88) min) and cardiopulmonary bypass time (153.5 (IQR = 134.5-177.5) versus 116 (IQR = 103-136) min), and all with <i>p</i> < 0.01. The majority of patients had posterior leaflet prolapse (65.6%, <i>n</i> = 926). The repair rate was 98.1%, <i>n</i> = 1385. Survival at ten-year follow-up for the patients included in the first 120 procedures was 91.5% (95% confidence interval (CI) = 86.4-96.6%) versus 92.8% (95% CI = 91.7-93.9%) for the patients who were in the latter group, <i>p</i> = 0.58. Freedom from >2+ mitral regurgitation at 5 years was 97.0% (95% CI = 95.3-98.7%) for the patients in the first 120 procedures and 92.7% (95% CI = 91.5-93.9%), <i>p</i> = 0.22, for those in the latter group. <b>Conclusions</b>: The robotic platform offers an excellent durable repair for mitral regurgitation in our experience of over 1400 patients. The robotic platform for mitral valve repair offers a teachable and safe approach to mitral valve disease for patients.